Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

858
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
858
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

467
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
467
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

1.0K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and molecular landscape of surgically resected early onset pancreatic cancer.

The British journal of surgery·2026
Same author

Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas.

Nature communications·2026
Same author

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.

Nature communications·2025
Same author

Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma.

British journal of cancer·2025
Same author

Improving outcomes of patients with pancreatic cancer.

Nature reviews. Clinical oncology·2025
Same author

nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K

Pancreatic cancer.

Jorg Kleeff1,2, Murray Korc3, Minoti Apte4

  • 1NIHR Pancreas Biomedical Research Unit, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Duncan Building, Daulby Street, Liverpool L69 3GA, UK.

Nature Reviews. Disease Primers
|May 10, 2016
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer remains a deadly disease with few effective treatments due to its complexity and late diagnosis. Future research must focus on novel therapeutic strategies and early detection to improve patient survival and quality of life.

More Related Videos

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

977
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.8K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

977
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.8K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer is a leading cause of cancer mortality with a poor prognosis, largely unchanged for decades.
  • Early detection is challenging due to asymptomatic presentation and lack of specific biomarkers.
  • Limited druggable targets and complex tumor biology, including genomic, epigenetic, and metabolic alterations, impede therapeutic progress.

Purpose of the Study:

  • To summarize current knowledge on pancreatic cancer's pathophysiology, molecular characteristics, and clinical management.
  • To outline future research directions and patient management strategies for pancreatic cancer.

Main Methods:

  • Review of current understanding of pancreatic cancer.
  • Synthesis of pathophysiological, molecular, translational, and clinical aspects.
  • Identification of future research and patient management avenues.

Main Results:

  • Pancreatic cancer exhibits complex genomic, epigenetic, and metabolic landscapes with limited prevalent druggable mutations.
  • The tumor microenvironment, involving neoplastic and stromal cells, presents significant challenges to treatment.
  • While neoadjuvant therapies and multimodal regimens can improve resectability and survival, most patients relapse post-surgery.

Conclusions:

  • Despite advances, pancreatic cancer remains a formidable disease requiring innovative approaches.
  • Future directions should emphasize early detection, novel therapeutic targets, and improved patient management strategies.
  • Addressing the complexity of pancreatic cancer biology and its microenvironment is crucial for improving outcomes.